The Efficacy of 0.1% Tacrolimus Ophthalmic Suspension in the Treatment of Severe Atopic Keratoconjunctivitis.

The Efficacy of 0.1% Tacrolimus Ophthalmic Suspension in the Treatment of Severe Atopic Keratoconjunctivitis. Ann Allergy Asthma Immunol. 2019 Jan 10;: Authors: Yazu H, Shimizu E, Aketa N, Dogru M, Okada N, Fukagawa K, Fujishima H PMID: 30639466 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30639466?dopt=Abstract

Source: Annals of Allergy, Asthma and Immunology - January 10, 2019 Category: Allergy & Immunology Authors: Yazu H, Shimizu E, Aketa N, Dogru M, Okada N, Fukagawa K, Fujishima H Tags: Ann Allergy Asthma Immunol Source Type: research